Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway

Toxicology and Industrial Health

Volumn 25, Issue 2, 2009, Pages 101-109

  Zhang, X ^a  

^a JIMEI UNIVERSITY   (China)

Author keywords

aberrant crypt foci; acrylamide; cancer; corn oil; mitochondria

Indexed keywords

ACRYLAMIDE; CASPASE 3; CORN OIL; CYTOCHROME C; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; COLON ADENOMA; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; CYTOSOL; DIET SUPPLEMENTATION; DIETARY INTAKE; DOWN REGULATION; ENZYME RELEASE; LONG TERM EXPOSURE; MALE; MITOCHONDRION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ACRYLAMIDE; ADENOCARCINOMA; ADENOMA; ANIMALS; APOPTOSIS; CARCINOGENICITY TESTS; CELL PROLIFERATION; COCARCINOGENESIS; COLON; COLONIC NEOPLASMS; CORN OIL; DIET; GENE EXPRESSION REGULATION, NEOPLASTIC; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; MALE; MITOCHONDRIA; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS; ZEA MAYS;

EID: 66249128910     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233709102948     Document Type: Article

References (53)

1. Arai T, Kida Y, Harmon BV, Gobe GC (1996) Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 74: 406–412.
2. Bartolí R Fernández-Bañares, F, Navarro, E, Castellà, E, Mañé, J, Alvarez, M, et al. (2000) Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis. Gut 46: 191–199.
3. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F (2002) Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 32: 306–311.
4. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147–151.
5. Brenner C, Kroemer G (2000) Apoptosis. Mitochondria—the death signal integrators. Science 289: 1150–1151.
6. Burton K (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323.
7. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T (2001) BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705–711.
8. Dai W, Liu T, Wang Q, Rao CV, Reddy BS (2002) Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Int J Oncol 20: 121–126.
9. Ding HF, Lin YL, McGill G, Juo P, Zhu H, Blenis J (2000) Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem 275: 38905–38911.
10. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1: 45–49.
11. FAO/WHO (2005) Summary and Conclusions of the Sixty-Fourth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Geneva: FAO/WHO.
12. Femia AP, Dolara P, Servili M, Esposto S, Taticchi A, Urbani S (2008) No effects of olive oils with different phenolic content compared to corn oil on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Eur J Nutr 47: 329–334.
13. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12: 2973–2983.
14. Greenspan EJ, Cyr JL, Pleau DC, Levine J, Rajan TV, Rosenberg DW (2007) Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis 28: 769–776.
15. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824–1827.
16. IARC (1994) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Some Industrial Chemicals. Lyon, 15–22 February 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 60: 1–560.
17. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27: 31–39.
18. Jedinak A, Sliva D (2008) Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int J Oncol 33: 1307–1313.
19. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA (2008) Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 68: 3985–3991.
20. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA (1986) Chronic toxicity and oncogenicity study on ACR incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85: 154–168.
21. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153–164.
22. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132–1136.
23. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.
24. Marsh GM, Lucas LJ, Youk AO, Schall LC (1999) Mortality patterns among workers exposed to ACR: 1994 follow up. Occup Environ Med 56: 181–190.
25. Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H (2002) p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 62: 2883–2889.
26. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577–590.
27. Mucci LA, Lindblad P, Steineck G, Adami HO (2004) Dietary ACR and risk of renal cell cancer. Int J Cancer 109: 774–776.
28. Nikolaev AY, Li M, Puskas N, Qin J, Gu W (2003) Parc: a cytoplasmic anchor for p53. Cell 112: 29–40.
29. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N (2006) The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett 244: 260–267.
30. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T (2000a) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053–1058.
31. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T (2000b) p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849–862.
32. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T (2003) Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124: 361–367.
33. Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15: 1049–1054.
34. Pretlow TP, Barrow BJ, Stellato TA (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 51: 1564–1567.
35. Prives C (1998) Signaling to p53: breaking the MDM2–p53 circuit. Cell 95: 5–8.
36. Raju J (2008) Azoxymethane-induced rat aberrant crypt foci: Relevance in studying chemoprevention of colon cancer. World J Gastroenterol 14: 6632–6635.
37. Rao CV, Hirose Y, Indranie C, Reddy BS (2001) Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61: 1927–1933.
38. Reddy BS (2000) Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9: 239–247.
39. Seo YW, Shin JN, Ko KH, Cha JH, Park JY, Lee BR (2003) The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278: 48292–48299.
40. Sharpless NE, DePinho RA (2002) p53: good cop/bad cop. Cell 110: 9–12.
41. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 1445–1449.
42. Takayama T, Katsuki S, Takahashi Y, Niitsu Y (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339: 1277–1284.
43. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Nakamura Y (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42–49.
44. Tavani A, Pelucchi C, Parpinel M, Negri E, Franceschi S, Levi F (2003) n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int J Cancer 105: 113–116.
45. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462.
46. Weiss G (2002) Cancer risks: ACR in food—uncharted territory. Science 297: 27.
47. Woods DB, Vousden KH (2001) Regulation of p53 function. Exp Cell Res 264: 56–66.
48. Wu B, Iwakiri R, Ootani A, Fujise T, Tsunada S, Fujimoto K (2003) Plateletactivating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemiareperfusion. FASEB J 17: 1156–1158.
49. Wu B, Iwakiri R, Tsunada S, Utsumi H, Kojima M, Fujise T (2002) iNOS enhances rat intestinal apoptosis after ischemiareperfusion. Free Radic Biol Med 33: 649–658.
50. Wu B, Ootani A, Iwakiri R, Fujise T, Tsunada S, Toda S (2004) Ischemic preconditioning attenuates ischemia/reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol 286: G580–G587.
51. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM (2001) Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20: 240–251.
52. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129–1132.
53. Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D (2003) P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 63: 3729–3734.